Dhansa Labs Annual General Meeting
Dhansa Labs Limited held its 41st Annual General Meeting on September 26, 2026, to adopt financial statements and ratify the cost auditor's remuneration.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Dhansa Labs Limited held its 41st Annual General Meeting on September 26, 2026, to adopt financial statements and ratify the cost auditor's remuneration.
Dhansa Labs Limited announced the voting results for its postal ballot. Shareholders approved the alteration of the object clause, asset mortgage/disposal, and a related party transaction.
Dhansa Labs Limited issued a notice for its Annual General Meeting scheduled for September 26, 2026. Agenda items include financial statement adoption and director reappointment.
Dhansa Labs Ltd reported revenue from operations of ₹30.6 Cr (+8.1% YoY) and net profit of ₹1.3 Cr (+8.3% YoY) for Q1 FY27.
Dhansa Labs reported FY26 revenue of ₹141.5cr (up 10.8% YoY) and PAT of ₹5.5cr (up 15.5% YoY). Strategy shifts toward diversification into renewable energy and agrochemical capacity expansion.
Dhansa Labs reports FY26 revenue growth of 10.82% while aggressively pivoting into capital-intensive green energy and biofuels via new subsidiaries.
Dhansa Labs (formerly Ambey Laboratories) reported strong FY26 performance with Revenue of ₹14,153.72 lakhs and PAT of ₹552.26 lakhs. The company is diversifying into Green Energy via CBG and Napier Grass projects.